Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Is it cost-effective to use genetic tools to predict how well patients with cystic fibrosis will respond to treatment?

Is it cost-effective to use genetic tools to predict how well patients with cystic fibrosis will respond to treatment?

Resource Type

CF Research News

Authors

Yeva Sahakyan, Lusine Abrahamyan, Felix Ratjen, Christine Bear, Lisa Strug, Paul D W Eckford, John K Peel, Murray Krahn, Beate Sander

References

J Cyst Fibros. 2023 Apr 24;S1569-1993(23)00119-4. doi: 10.1016/j.jcf.2023.04.013.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Care of patients with CF [3]
Epidemiology/Models of care [4]

Date

Monday, April 24, 2023

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [5]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/it-cost-effective-use-genetic-tools-predict-how-well-patients

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-23-00027R2_FINAL_Sahakyan_070523.pdf [2] https://pubmed.ncbi.nlm.nih.gov/37100704/ [3] https://www.ecfs.eu/research-article-themes/care-patients-cf [4] https://www.ecfs.eu/research-article-themes/epidemiologymodels-care [5] https://www.ecfs.eu/resource-guideline-type/other-guidelines